PROTECT Data and Teplizumab in Newly Diagnosed T1D
Oct 25, 2023, 03:27 PM
In this episode, hosts discuss data from the PROTECT trial, which examined the effects of teplizumab on beta-cell function in patients with newly diagnosed type 1 diabetes.